Irsko - angličtina - HPRA (Health Products Regulatory Authority)

rowex ltd - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid - other antibacterials - it is indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria and for the treatment of complicated skin and soft tissue infections

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: citric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; hydrochloric acid; glucose monohydrate - linezolid sandoz is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics,including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Kanada - angličtina - Health Canada

sandoz canada incorporated - linezolid - solution - 2mg - linezolid 2mg - oxazolidinones

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: citric acid; sodium hydroxide; sodium citrate dihydrate; water for injections; hydrochloric acid; glucose monohydrate - linezolid sz is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics,including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Spojené státy - angličtina - NLM (National Library of Medicine)

sandoz inc - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 200 mg in 100 ml - linezolid is indicated for the treatment of nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and - resistant isolates) or streptococcus pneumoniae [see clinical studies (14)]. linezolid is indicated for the treatment of community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14)]. linezolid is indicated for the treatment of complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or streptococcus agalactiae . linezolid injection has not been studied in the treatment of decubitus ulcers [see clinical studies (14)]. linezolid is indicated for the treatment of uncomplicated skin and skin structure infections caused by staphylococcus aureus (methicillin-susceptible isolates

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - linezolid - oral tablet - 600mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - infusion (parenteral) - see ingredients - each 1,0 ml solution contains : linezolid 2,0 mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - linezolid, quantity: 600 mg - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; ethylcellulose; silicon dioxide; povidone; microcrystalline cellulose; diethyl phthalate; purified talc - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. it has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram- negative pathogen is documented or suspected.

Kanada - angličtina - Health Canada

sandoz canada incorporated - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists

Kanada - angličtina - Health Canada

sandoz canada incorporated - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists